LINTEX
920106
LINGOOD
833284
NTGEC
870436
4
CG MED EQUIP.
838810
5
Jiayu Holding
300117
US Stock MarketDetailed Quotes
PFE Pfizer
- 26.430
- +0.330+1.26%
Close Feb 28 16:00 ET
- 26.350
- -0.080-0.30%
Post 19:59 ET
149.79BMarket Cap18.74P/E (TTM)
26.490High25.910Low51.53MVolume26.055Open26.100Pre Close1.35BTurnover0.91%Turnover Ratio18.74P/E (Static)5.67BShares30.55252wk High1.70P/B149.56BFloat Cap23.71352wk Low1.68Dividend TTM5.66BShs Float53.002Historical High6.36%Div YieldTTM2.22%Amplitude5.306Historical Low26.272Avg Price1Lot Size
Pfizer Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 29, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Oct 1, 2023 | (Q2)Jul 2, 2023 | (Q1)Apr 2, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 46.45%12.74B | 28.22%6.72B | 94.13%6.71B | -47.31%-1.78B | -9.91%1.09B | -70.27%8.7B | -38.93%5.24B | -42.07%3.46B | -114.79%-1.21B | 1.21B |
| Net income from continuing operations | 270.67%8.05B | 112.32%411M | 287.65%4.48B | -98.68%31M | -43.69%3.13B | -93.08%2.17B | -166.69%-3.34B | -127.63%-2.39B | -76.31%2.34B | --5.56B |
| Depreciation and amortization | 11.49%7.01B | 7.25%1.79B | 12.50%1.76B | 10.04%1.73B | 16.75%1.74B | 24.21%6.29B | 9.94%1.67B | 31.87%1.56B | 33.87%1.57B | --1.49B |
| Deferred tax | 38.93%-2.1B | 78.69%-396M | -326.55%-482M | 10.31%-783M | 26.25%-441M | 8.55%-3.44B | -409.04%-1.86B | -282.26%-113M | 23.42%-873M | ---598M |
| Other non cash items | 46.94%-2.27B | 56.01%-1.35B | -46.69%-842M | 151.02%274M | -253.00%-353M | -970.00%-4.28B | -127.50%-3.07B | -228.00%-574M | -175.10%-537M | ---100M |
| Change In working capital | -41.16%-3.07B | -65.37%2.93B | 173.31%879M | 9.73%-3.54B | 39.42%-3.34B | 61.48%-2.17B | 246.03%8.45B | 73.85%-1.2B | -41.58%-3.92B | ---5.51B |
| -Change in receivables | -131.41%-109M | ---- | ---- | ---- | ---- | 32.95%347M | ---- | ---- | ---- | ---- |
| -Change in inventory | 26.95%-854M | ---- | ---- | ---- | ---- | -97.80%-1.17B | ---- | ---- | ---- | ---- |
| -Change in payables and accrued expense | -241.00%-1.02B | ---- | ---- | ---- | ---- | -125.19%-300M | ---- | ---- | ---- | ---- |
| -Change in other current assets | 609.80%3.38B | ---- | ---- | ---- | ---- | 85.29%-663M | ---- | ---- | ---- | ---- |
| -Change in other current liabilities | -623.53%-3.12B | ---- | ---- | ---- | ---- | 141.06%595M | ---- | ---- | ---- | ---- |
| -Change in other working capital | -36.97%-1.35B | ---- | ---- | ---- | ---- | -80.18%-982M | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 46.48%12.74B | 28.26%6.72B | 94.27%6.71B | -47.43%-1.78B | -10.07%1.09B | -70.27%8.7B | -38.94%5.24B | -42.15%3.46B | -114.79%-1.21B | --1.21B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 108.22%2.65B | 85.27%-1.62B | -331.24%-2.06B | 118.05%4.6B | -47.80%1.73B | -104.50%-32.28B | -149.31%-11B | 242.40%890M | -125.26%-25.49B | 3.32B |
| Net PPE purchase and sale | 25.54%-2.91B | 12.16%-917M | 19.63%-651M | 30.31%-637M | 38.19%-704M | -20.74%-3.91B | -4.30%-1.04B | 3.69%-810M | -21.70%-914M | ---1.14B |
| Net business purchase and sale | 116.21%7.04B | 108.18%3.55B | --0 | --0 | --3.49B | -88.85%-43.43B | -158.79%-43.41B | --0 | ---25M | --0 |
| Net investment purchase and sale | -109.71%-1.48B | -112.76%-4.27B | -204.59%-1.41B | 121.88%5.26B | -123.61%-1.06B | 128.06%15.24B | 150.40%33.44B | 137.14%1.35B | -129.11%-24.02B | --4.47B |
| Net other investing changes | ---- | ---- | -98.28%6M | 96.37%-19M | 105.26%1M | 6.25%-180M | 66.67%15M | 413.51%348M | -580.52%-524M | ---19M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 108.22%2.65B | 85.24%-1.62B | -331.64%-2.06B | 118.05%4.6B | -47.75%1.73B | -104.51%-32.28B | -149.34%-11B | 241.63%888M | -125.27%-25.49B | --3.32B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -165.75%-17.14B | -193.97%-5.11B | -22.68%-4.64B | -109.05%-2.46B | -77.95%-4.93B | 275.72%26.07B | 208.51%5.44B | 34.40%-3.78B | 977.95%27.18B | -2.77B |
| Net issuance payments of debt | -119.92%-7.16B | -134.98%-2.72B | -57.56%-2.25B | -100.05%-16M | -6,690.63%-2.17B | 1,122.33%35.95B | 379.98%7.78B | 59.44%-1.43B | 542.59%29.63B | ---32M |
| Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash dividends paid | -2.87%-9.51B | -2.81%-2.38B | -2.85%-2.38B | -2.81%-2.38B | -3.00%-2.37B | -2.94%-9.25B | -3.12%-2.32B | -3.07%-2.31B | -3.16%-2.32B | ---2.3B |
| Net other financing activities | 25.79%-469M | 22.22%-14M | 83.78%-6M | 55.32%-63M | 11.47%-386M | -88.66%-632M | -357.14%-18M | -840.00%-37M | -192.16%-141M | ---436M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -165.76%-17.14B | -193.97%-5.11B | -22.68%-4.64B | -109.05%-2.46B | -77.95%-4.93B | 275.72%26.07B | 208.51%5.44B | 34.40%-3.78B | 978.33%27.17B | ---2.77B |
| Net cash flow | ||||||||||
| Beginning cash position | 523.29%2.92B | -64.37%1.15B | -58.38%1.12B | -64.90%780M | 523.29%2.92B | -76.40%468M | 141.63%3.23B | 47.92%2.7B | -11.58%2.22B | --468M |
| Current changes in cash | -170.07%-1.74B | 94.92%-16M | -96.47%20M | -24.95%361M | -220.10%-2.11B | 284.37%2.49B | 62.68%-315M | 236.96%567M | 177.21%481M | --1.76B |
| Effect of exchange rate changes | -65.00%-66M | -2,800.00%-29M | 128.13%9M | -260.00%-18M | -1,300.00%-28M | 75.76%-40M | 96.15%-1M | 55.56%-32M | 92.42%-5M | ---2M |
| End cash Position | -62.05%1.11B | -62.05%1.11B | -64.37%1.15B | -58.38%1.12B | -64.90%780M | 523.29%2.92B | 523.29%2.92B | 141.63%3.23B | 47.92%2.7B | --2.22B |
| Free cash flow | 105.20%9.84B | 38.32%5.8B | 129.14%6.06B | -13.95%-2.42B | 428.77%386M | -81.59%4.79B | -44.65%4.2B | -48.45%2.65B | -128.60%-2.12B | --73M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Trending Stocks
Discussing
Tesla's earnings caused fluctuations, what's your market outlook？
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum
Moo Earnings
Jan 24 10:26
TSLA earnings preview: Grab rewards by guessing the opening price!